ABOUT THIS EPISODE
We break down what continuous glucose monitors really measure and how to use CGM data without letting a new health metric run your life. We walk through a new primary care study in type 2 diabetes without insulin and talk honestly about benefits, limits, cost, and the questions the research still leaves open.
• separating A1C, fingerstick glucose, and CGM trend data
• why CGM readings can lag behind finger sticks
• what the Kinect trial studied and why it matters for non-insulin type 2 diabetes
• A1C changes, time in range, and what “better control” can mean day to day
• medication intensification versus behavior change as competing explanations
• sponsorship and study design caveats worth noticing
• using CGMs to spot meal spikes and guide realistic nutrition choices
• consumer CGMs for prediabetes curiosity and time-limited learning
• cost, access, and why long-term real-world results may differ
You can find us on Instagram, threads, send us an email, send us a voicemail if you'd like
Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN
Artwork Rebrand and Avatars:
Vantage Design Works (Vanessa Jones)
Website: https://www.vantagedesignworks.com/
Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr
Original Artwork Concept: Olivia Pawlowski
IN THIS EPISODE
SHOW NOTES 🔗
TRANSCRIPT 🔗
00:00:03.040 --> 00:00:04.559
Hi, welcome to your checkup.
00:00:04.719 --> 00:00:09.919
We are the Patient Education Podcast where we bring conversations from the doctor's office to your ears.
00:00:10.080 --> 00:00:13.279
On this podcast, we try to bring medicine closer to its patients.
00:00:13.359 --> 00:00:17.679
I'm Ed Delesky, a family medicine doctor and obesity medicine specialist in the Philadelphia area.
00:00:17.839 --> 00:00:18.960
And I'm Nicola Roofelt.
00:00:19.120 --> 00:…